Joan edukira
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Hizkuntza
Eremu guztiak
Izenburua
Egilea
Gaia
Sailkapena
ISBN/ISSN
Etiketa
Bilatu
Aurreratua
Osteoprotegerin inhibits the d...
Erreferentzia bihurtu
SMS
Bidali
Imprimir
Erregistroa esportatu
Nora RefWorks
Nora EndNoteWeb
Nora EndNote
Permanent link
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Show other versions (1)
Xehetasun bibliografikoak
Egile Nagusiak:
Croucher, P
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Asosingh, K
,
van Beek, E
,
Van Camp, B
,
Russell, R
,
Dunstan, C
,
Vanderkerken, K
Formatua:
Journal article
Argitaratua:
2001
Aleari buruzko argibideak
Deskribapena
Other Versions (1)
Antzeko izenburuak
MARC erregistroa
Antzeko izenburuak
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
nork: Croucher, P, et al.
Argitaratua: (2001)
Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
nork: Croucher, P, et al.
Argitaratua: (2000)
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
nork: Croucher, P, et al.
Argitaratua: (2003)
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
nork: Croucher, P, et al.
Argitaratua: (2001)
Osteoprotegerin and the development of myeloma bone disease
nork: Croucher, P, et al.
Argitaratua: (2004)